Assignee profile:

Baxalta GmbH

City:

Opfikon

Country:

Switzerland

Published Applications:

11

Last publication date:

2019-07-25

Patent Grants:

10

Last grant date:

2020-11-03

Top Inventors for applications by Baxalta GmbH

These are the the leading inventors for applications assigned to Baxalta GmbH:

Recent patent applications by Baxalta GmbH

Baxalta GmbH based in Opfikon, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-07-25 ✅ Patent 10,822,376 granted on 2020-11-03
US20190225648A1
Chemistry; metallurgy

Biologically active peptides

#2 | 2017-05-04
US20170119857A1
Human necessities

Method of Administering Porcine B-Domainless fVIII

#3 | 2014-11-13 ✅ Patent 9,309,506 granted on 2016-04-12
US20140335071A1
Chemistry; metallurgy

Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#4 | 2014-11-06 ✅ Patent 9,234,051 granted on 2016-01-12
US20140328827A1
Chemistry; metallurgy

Methods for fucoidan purification from seaweed extracts

#5 | 2014-03-20 ✅ Patent 9,808,570 granted on 2017-11-07
US20140078854A1
Human necessities

Syringe storage tray

#6 | 2014-02-13 ✅ Patent 9,187,732 granted on 2015-11-17
US20140045245A1
Chemistry; metallurgy

Replication deficient influenza virus for the expression of heterologous sequences

#7 | 2013-12-26 ✅ Patent 9,670,456 granted on 2017-06-06
US20130344535A1
Chemistry; metallurgy

Virus filtration of cell culture media

#8 | 2013-02-07 ✅ Patent 9,534,037 granted on 2017-01-03
US20130034876A1
Chemistry; metallurgy

Systems and methods to increase protein yield from recombinant manufacturing processes

#9 | 2012-07-19 ✅ Patent 9,488,625 granted on 2016-11-08
US20120184715A1
Physics

Purification of factor VIII using a conductivity gradient

#10 | 2012-06-21 ✅ Patent 9,200,031 granted on 2015-12-01
US20120153221A1
Chemistry; metallurgy

Real time monitoring and control of protein production processes using impedance spectroscopy

#11 | 2010-05-06 ✅ Patent 9,587,249 granted on 2017-03-07
US20100115637A1
Human necessities

Models of thrombotic thrombocytopenic purpura and methods of use thereof

Also check out Baxalta GmbH's (Opfikon, Switzerland) applicant profile with 4 patent applications submitted.

AssigneeID:

121626 ⎘